Skip to main content
Caplight Logo









EndoStart

EndoStart

Private
CertaldoHealthcare & Life Scienceshttps://endostart.com/

Last Round

VC Round

Sep 12, 2022

Total Funding Raised

$11.14M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

EndoStart is a medical technology company that develops and manufactures innovative gastrointestinal endoscopy devices, including its proprietary Magnetic Balloon Anchoring Technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

gastrointestinal endoscopycolonoscopymedical deviceendoscopeenteroscopyendoscopic guidewiremagnetic balloon anchoringMBATgastroenterology equipmentendoscopy accessoriesgi scopemedtechendoscope stabilizationprocedural efficiency

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EndoStart Comparables

Compare EndoStart with similar companies based on industry and business-model similarity.

EndoStart comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SMART Medical Systems Ltd.
85%
Lumendi
85%
Neptune Medical
78%

EndoStart Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 12, 2022
Series BJun 4, 2021
SeedDec 20, 2018

Key People

Founding team and executive leadership

Alessandro Tozzi

CEO, Founder

Founding Team

Roberto Ghidini

CTO

Executive Team

FLAVIO VENTURI

Chief Financial Officer

Executive Team

EndoStart Investors

Notable investors and investment history

EndoStart investors
InvestorRounds
EUREKA! Venture SGRVC Round, Series B
Kairos Partners SGRVC Round
Panakès PartnersVC Round, Series B, Seed
LIFTT EuroInvestVC Round, Series B
A11 VentureVC Round, Series B, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 5894% MoM, reaching 1K.

  • Jan 20, 2026

    Monthly visitors grew 927% MoM, reaching 2.3K.

EndoStart Filings

Explore SEC and related filing metadata, where available.

EndoStart filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EndoStart's valuation, stock price, and market status.

Is EndoStart a public or private company?

EndoStart is a private company.

What is the current stock price of EndoStart?

EndoStart is a private company with no public stock price. No recent secondary market data is available.

How much is EndoStart worth (valuation)?

Valuation information for EndoStart is not publicly available.

Can I buy EndoStart stock?

EndoStart shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EndoStart's last funding round?

EndoStart's most recent funding round was VC Round on September 12, 2022.

Who are the main investors in EndoStart?

Key investors in EndoStart include Kairos Partners SGR, Panakès Partners.

Will EndoStart IPO soon?

No public IPO plans have been announced for EndoStart.

How can I track EndoStart secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EndoStart's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCertaldo
Employee Range18
Year Founded2018
Last FundingSep 12, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?